Long term prognosis of children born to lupus patients

Annals of the Rheumatic Diseases

Volumn 63, Issue 1, 2004, Pages 50-53

  Murashima, A ^a,b   Fukazawa, T ^b   Hirashima, M ^b   Takasaki, Y ^b   Oonishi, M ^b   Niijima, S ^b   Yamashiro, Y ^b   Yamataka, A ^b   Miyano, T ^b   Hashimoto, H ^b  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGENY; PROGNOSIS; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS;

EID: 9144263600     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2002.001594     Document Type: Article

References (18)

1. Harris EN, Ghavari AE, Hughes GRV. The anti-cardiolipin assay. In: Harris EN, Exner T, Hughes GRV, Asherson RA, eds. Phospholipid-binding antibodies. Boca Raton, FL: CRC Press, 1991:175-87.
2. Takasaki Y, Fishwild D, Tan EM. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984;159:981-92.
3. Sasai K, Furukawa S, Hashimoto H, Yabuta K. Increased levels of serum IgE in children of mothers with systemic lupus erythematosus. Allergy 1995;50:370-3.
4. Brunjes S, Zike K, Julian R. Familial systemic lupus erythematosus. Am J Med 1961;30:529-36.
5. Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus 1. Heritability. J Rheumatol 1987;14:913-21.
6. Arnett FC. The genetics of human lupus. In: Wallace DJ, Hahn BW, eds. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins, 1997:101-3.
7. Leonhardt T. Family studies in SLE. Clin Exp Immunol 1967;2:743-59.
8. Buckman KJ, Moore SK, Ebbin AJ, Cox MB, Dubois EL. Familial systemic lupus erythematosus. Arch Intern Med 1978;138:1674-16.
9. Nakae K, Furasa WF, Kasukawa R, et al. A nationwide epidemiological survey on diffuse collagen diseases; estimation of prevalence rate in Japan. In: Kasukawa R, Missouri GL, eds. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier, 1987:9-20.
10. EL-Roeiy A, Gleicher N, Isenberg D, Kennedy RC, Shoenfeld Y. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with SLE. Clin Exp Immunol 1987;68:528-34.
11. Zurgil N, Bakimer R, Tincani A, Faden D, Cohen J, Lorber M, et al. Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus 1993;2:233-7.
12. Takei S, Maeno N, Shigemori M, Imanaka H, Hokonohara M, Miyata K, et al. Clinical features of Japanese children ond adolescents with systemic lupus erythematosus: results of 1980-1994 survey. Acta Paediatr Jpn 1997;39:250-6.
13. Tan EM, Feltkamp TEW, Smolen JS, Butcher B, Dawkins R, Takasaki Y, et al. Range of antinuclecr antibodies in "healthy" individuals. Arthritis Rheum 1997;40:1601-111.
14. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998;19:352-7.
15. Arroyave CM, Giambrone MJ, Rich KC, Walaszek M. The frequency of antinuclear antibody in children by use of mouse kidney (MK) and human epithelial cells (HEp-2) as substrates. J Allergy Clin Immunol 1988;82:741-74.
16. Osborn TG, Patel NJ, Moore TL, Zuckner J. Use of the HEp-2 cell substrate in the detection of antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1984;27:1286-19.
17. Nelson JL. Microchimerism and human autoimmune diseases. Lupus 2002;11:651-4.
18. Artlett CM, Miller FW, Rider LG. Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001;40:1279-84.